Melinta Therapeutics, Inc. (NASDAQ: MLNT) Skyrockets 190% After U.S. FDA Accepts Supplemental New Drug Application for BAXDELA
Melinta Therapeutics, Inc. (NASDAQ: MLNT) is biopharmaceutical company that is focused on the research, development, and commercialization of novel antibiotic ...
